Trauma-Focused Intervention With Women Experiencing Homelessness
Homelessness and associated traumas disproportionately affect women. The biopsychosocial health consequences of untreated trauma are profound. PTSD frequently co-occurs with other chronic health conditions, including substance use disorders (SUD). Co-morbid PTSD and SUD (PTSD+SUD) is common and difficult to treat, resulting in severe morbidity and premature mortality among women experiencing homelessness. Executing this study will help to address the disproportionate PTSD+SUD comorbidity burden, which drives health inequities in the growing population of women experiencing homelessness within and beyond Chicago.
Conditions:
🦠 Psychological Trauma 🦠 Trauma and Stress Related Disorders 🦠 Substance-Related Disorders 🦠 Substance Use 🦠 Substance Use Disorders
🗓️ Study Start (Actual) 1 August 2022
🗓️ Primary Completion (Estimated) 31 December 2024
✅ Study Completion (Estimated) 30 March 2025
👥 Enrollment (Estimated) 50
🔬 Study Type INTERVENTIONAL
📊 Phase PHASE1
Locations:
📍 Chicago, Illinois, United States
📍 Chicago, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * self-identifies as a woman;
    • * greater than or equal to 18 years;
    • * positive screen on TAPS-1 (reflecting problematic substance use);
    • * recently (within 1 year) or currently homeless (HRSA definition);
    • * affected by a traumatic life event and trauma-related distress (+Life Events Checklist for DSM-5 Standard \[LEC-5\] response ≥1 and PTSD Checklist for DSM-5 \[PCL-5\] score ≥28).

    Exclusion Criteria:

    • - impaired decisional capacity to consent to participation (University of California, San Diego Brief Assessment of Capacity to Consent \[UBACC\] score ≤14.5)
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 12 April 2023
  • First Submitted that Met QC Criteria 15 May 2023
  • First Posted 24 May 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 27 June 2024
  • Last Update Posted 28 June 2024
  • Last Verified June 2024